Literature DB >> 11180381

Hexaphyrin(1.0.1.0.0.0): An Expanded Porphyrin Ligand for the Actinide Cations Uranyl (UO(2)(2+)) and Neptunyl (NpO(2)(+)) This work was supported by the National Science Foundation (grant CHE-9725399 to J.L.S.), the Office of Basic Energy Sciences, Division of Chemical Sciences, and Defense Programs, US Department of Energy, under Contract W-7405-eng-36 with the University of California (D.W.K.).

Jonathan L. Sessler1, Daniel Seidel, Anne E. Vivian, Brian L. Scott, D. Webster Keogh.   

Abstract

Entities:  

Year:  2001        PMID: 11180381

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  5 in total

Review 1.  Transition-metal complexes of expanded porphyrins.

Authors:  Jonathan L Sessler; Elisa Tomat
Journal:  Acc Chem Res       Date:  2007-03-31       Impact factor: 22.384

2.  Structural/electronic properties and reaction energies of a series of mono- and bis-uranyl dihalides equatorially coordinated by N/O ligands.

Authors:  Jun Yao; Yong-Ming Wang; Qing-Jiang Pan; Yuan-Ru Guo; Hong-Xing Zhang
Journal:  J Mol Model       Date:  2014-05-29       Impact factor: 1.810

3.  Oligopyrrole macrocycles: receptors and chemosensors for potentially hazardous materials.

Authors:  Brett M Rambo; Jonathan L Sessler
Journal:  Chemistry       Date:  2011-04-04       Impact factor: 5.236

4.  Theoretical investigation of the aromaticity and electronic properties of protonated and unprotonated molecules in the series hexaphyrin(1.0.0.1.0.0) to hexaphyrin(1.1.1.1.1.1).

Authors:  Gang Sun; Xi-Xin Duan; Chun-Hui Yu; Chun-Guang Liu
Journal:  J Mol Model       Date:  2015-11-20       Impact factor: 1.810

5.  UO2 2+-mediated ring contraction of pyrihexaphyrin: synthesis of a contracted expanded porphyrin-uranyl complex.

Authors:  James T Brewster; Harrison D Root; Daniel Mangel; Adam Samia; Hadiqa Zafar; Adam C Sedgwick; Vincent M Lynch; Jonathan L Sessler
Journal:  Chem Sci       Date:  2019-04-30       Impact factor: 9.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.